Artificial Intelligence (AI) is already transforming the way scientists design new medicines. In recent years, AI systems have helped researchers create potential drugs for antibiotic-resistant infections and even rare genetic diseases. However, when it comes to designing the tiny delivery systems that carry these drugs into human cells, progress has been slower. One of the most important delivery systems in modern medicine is lipid nanoparticles (LNPs) . These microscopic fat-based particles protect fragile genetic material and transport it safely into cells. LNPs played a crucial role in the development of mRNA vaccines during the COVID-19 pandemic, proving that they can revolutionize the field of medicine. Despite their importance, designing better lipid nanoparticles remains a major challenge. Scientists must carefully balance several chemical ingredients, and even small changes in these ingredients can significantly affect how the particles behave inside the body. Now, engineers a...